|
Index of reports
> Cases with Tremor ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include tremor. The selected reports were submitted to the FDA during the sample period of about a year.
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Fatigue, Alopecia, Vision Blurred, Depression, Rash, Tremor
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Contusion, Head Discomfort, Somnolence, Fall, Abdominal Pain Upper, Loss of Consciousness, Fatigue, Dizziness, Blood Creatinine Increased, Migraine, Back Pain, Nausea, Hypotension, Convulsion, Eye Pain, Tremor
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-09
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-07
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-09
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-03-09
Other drugs received by patient: Valium; Advil; Xanax; Ambien
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Tremor
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-22
End date: 2012-07-13
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-22
End date: 2012-07-13
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-04
Patient:
Reactions: Back Pain, Contusion, Head Discomfort, Nausea, Hypotension, Fall, Eye Pain, Loss of Consciousness, Convulsion, Tremor, Abdominal Pain Upper, Fatigue, Dizziness, Blood Creatinine Increased
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-09
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-09
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-07
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-07-05
Patient:
Reactions: Collagen Disorder, Blood Uric Acid Increased, Haemorrhoids, Disseminated Intravascular Coagulation, Erythema Multiforme, Tremor
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2011-12-21
End date: 2012-03-07
Rebetol
Dosage: 400 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-21
End date: 2012-03-14
Telavic (Antivirals Nos)
Dosage: 1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-21
End date: 2012-03-13
Other drugs received by patient: Loxonin; Zoloft; Maglax; Meilax; Primperan TAB; Betamethasone Sodium Phosphate; Nitrazepam; Voltaren; Selbrex
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: female
Reactions: Drug Dose Omission, Confusional State, Vomiting, Nausea, Drug Withdrawal Syndrome, Tremor, Diarrhoea, Neck Pain, Presyncope, Cold Sweat
Drug(s) suspected as cause:
Morphine
Indication: Product Used FOR Unknown Indication
PEG-Intron
Indication: Hepatitis C
Start date: 2012-03-18
Ribavirin
Indication: Hepatitis C
Start date: 2012-03-18
Victrelis
Indication: Hepatitis C
Start date: 2012-04-15
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient: female
Reactions: Weight Decreased, Pneumonia, Hepatitis C, Abasia, Fall, Tremor, Concussion, Disease Recurrence, Facial Bones Fracture
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2003-01-01
End date: 2003-07-01
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-14
Ribavirin
Indication: Hepatitis C
Start date: 2012-02-14
Ribavirin
Indication: Hepatitis C
Start date: 2003-01-01
End date: 2003-07-01
Possible PEG-Intron side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient: 56 year old female
Reactions: Weight Decreased, Nausea, Faecal Incontinence, Headache, Fall, Hyperhidrosis, Tremor, Injection Site Erythema, Diarrhoea, RED Blood Cell Count Decreased, Balance Disorder, Hypophagia, Alopecia, Injection Site Rash, Hallucination
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-06-16
Ribavirin
Indication: Hepatitis C
Start date: 2011-06-16
Victrelis
Indication: Hepatitis C
Start date: 2011-07-28
End date: 2011-08-05
Possible PEG-Intron side effects in 5 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09
Patient: 5 year old male, weighing 32.5 kg (71.5 pounds)
Reactions: Renal Tubular Disorder, Dyskinesia, Disseminated Intravascular Coagulation, Petechiae, Hepatic Failure, Mental Status Changes, Coma, Headache, Pyrexia, Lactic Acidosis, Urine Output Increased, Generalised Oedema, Malaise, Acute Respiratory Distress Syndrome, Pulmonary Oedema, Electrolyte Imbalance, Vomiting, International Normalised Ratio Increased, Respiratory Distress, Tremor, Nephrogenic Diabetes Insipidus, Convulsion, Renal Failure, Product Packaging Issue, Mitochondrial Toxicity, Depressed Level of Consciousness, Rash Maculo-Papular, Multi-Organ Disorder, Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: 445 mg;once;rtl
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
Acetaminophen
Dosage: 400 mg;once ; 400 mg;once
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
Acetaminophen
Dosage: 400 mg;once ; 400 mg;once
Indication: Product Used FOR Unknown Indication
Start date: 2010-01-07
PEG-Intron
Dosage: 64 mcg;sc
Indication: Hepatitis C
Start date: 2010-01-07
End date: 2010-01-07
Rebetol
Dosage: 240 mg;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-07
End date: 2010-01-07
Possible PEG-Intron side effects in 53 year old female
Reported by a physician from Japan on 2012-04-13
Patient: 53 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Nausea, Haemorrhoids, Disseminated Intravascular Coagulation, Rash Papular, Tremor, Collagen Disorder, Blood Uric Acid Increased, Injection Site Reaction, Erythema Multiforme, Papule
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3 mcg/kg;qw;sc
Indication: Hepatitis C
Start date: 2011-12-21
Rebetol
Dosage: 400 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-21
Telavic (Antivirals Nos)
Dosage: 1500 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-21
End date: 2012-03-13
Other drugs received by patient: Voltaren / 01160501 /; Primperan / 00041902 /; Magnesium Sulfate; Loxonin / 00890701 /; Selbex; Zoloft; Rinderon-VG; Meilax; Nitrazepam
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Nausea, Dehydration, Asthenia, Tremor, Walking AID User
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-10-07
End date: 2011-10-19
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-10-19
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-09-21
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
Blinded MK-5172
Dosage: 8; 3 df
Indication: Hepatitis C
Start date: 2011-10-06
End date: 2011-10-06
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-14
End date: 2011-11-14
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-21
End date: 2011-11-21
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-11-29
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-01-02
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-12-12
End date: 2011-12-12
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2011-11-07
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-31
End date: 2011-10-31
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-10
End date: 2011-10-10
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2011-12-05
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2012-01-08
End date: 2012-01-08
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2011-09-26
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-10-03
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-17
End date: 2011-10-17
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-12-19
End date: 2011-12-19
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-24
End date: 2011-10-24
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-12-26
End date: 2011-12-26
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-23
End date: 2011-11-28
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-24
End date: 2011-11-28
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-06
End date: 2011-10-06
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-07
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-15
End date: 2011-12-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-22
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-20
End date: 2012-01-03
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-10-05
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-15
End date: 2012-01-11
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
End date: 2012-01-10
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-12-14
Other drugs received by patient: Deplin; Lysine; Effexor; Ibuprofen; Effexor; Loratadine; Wellbutrin; Vitamin B Complex CAP; Valtrex; Wellbutrin; Omeprazole; Zofran; Wellbutrin; Ibuprofen
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2012-02-09
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-10-06
End date: 2011-10-07
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-10-19
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Blinded MK-5172
Dosage: see image
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-09-22
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-11-14
End date: 2011-11-14
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-11-21
End date: 2011-11-21
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-10-03
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-10-24
End date: 2011-10-24
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-12-26
End date: 2011-12-26
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2011-11-07
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-12-12
End date: 2011-12-12
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2011-09-26
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2011-12-05
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-10-10
End date: 2011-10-10
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-10-31
End date: 2011-10-31
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-12-19
End date: 2011-12-19
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-01-02
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-10-17
End date: 2011-10-17
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-11-29
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2012-01-08
End date: 2012-01-08
Placebo
Dosage: df;tid;po df;unk; unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Placebo
Dosage: df;tid;po df;unk; unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-09-21
End date: 2011-10-05
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-12-14
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-12-14
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-12-15
End date: 2012-01-11
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-12-20
End date: 2012-01-03
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-22
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-10-07
End date: 2011-11-16
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-24
End date: 2011-11-28
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2012-01-04
End date: 2012-01-10
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-11-23
End date: 2011-11-28
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-12-15
End date: 2011-12-19
Rebetol
Dosage: see image
Indication: Hepatitis C
Start date: 2011-10-06
End date: 2011-10-07
Other drugs received by patient: Loratadine; Lysine; Wellbutrin; Valtrex; Ibuprofen; Effexor; Deplin; Vitamin B Complex CAP; Omeprazole
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-19
Patient: female
Reactions: Vomiting, Pleuritic Pain, Pleurisy, Anaemia, Hypotension, Pyrexia, Tremor, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-10-30
Ribavirin
Indication: Hepatitis C
Start date: 2011-10-30
Victrelis
Indication: Hepatitis C
Start date: 2011-11-27
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2012-01-03
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2011-09-26
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-24
End date: 2011-10-24
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-14
End date: 2011-11-14
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-10
End date: 2011-10-10
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-31
End date: 2011-10-31
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-17
End date: 2011-10-17
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-10-03
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2011-11-07
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-24
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-29
Other drugs received by patient: Ibuprofen; Ibuprofen; Wellbutrin XL; Omeprazole; Wellbutrin; Effexor; Lysine; Vitamin B Complex CAP; Loratadine; Deplin; Valtrex
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2012-01-03
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Nausea, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Dosage: 8 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
Blinded MK-5172
Dosage: 8 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Blinded MK-5172
Dosage: 8 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Blinded MK-5172
Dosage: 8 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2011-09-26
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-10-03
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-10
End date: 2011-10-10
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-14
End date: 2011-11-14
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-17
End date: 2011-10-17
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-31
End date: 2011-10-31
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-24
End date: 2011-10-24
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2011-11-07
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-29
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-24
Other drugs received by patient: Vitamin B Complex CAP; Lysine; Wellbutrin XL; Loratadine; Ibuprofen; Effexor; Valtrex; Deplin; Omeprazole; Wellbutrin; Ibuprofen
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2012-01-03
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Nausea, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-11-16
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Blinded MK-5172
Dosage: 8 df
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-26
End date: 2011-09-26
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-10-03
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-24
End date: 2011-10-24
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-17
End date: 2011-10-17
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-09-20
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-31
End date: 2011-10-31
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-10-10
End date: 2011-10-10
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-14
End date: 2011-11-14
PEG-Intron
Dosage: 0.4 ml, qw, sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2011-11-07
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Placebo
Dosage: 12 df, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-17
End date: 2011-11-23
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-29
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2011-10-19
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2011-11-16
Rebetol
Dosage: 2;3 df, qam, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-24
Other drugs received by patient: Omeprazole; Deplin; Lysine; Wellbutrin; Wellbutrin; Omeprazole; Loratadine; Effexor; Valtrex; Vitamin B Complex CAP; Ibuprofen
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-28
Patient: female
Reactions: Dyspnoea, Somnolence, Tremor, Blood Glucose Abnormal, Insomnia, Abdominal Distension, Thyroid Disorder, Platelet Count Decreased, Asthenia, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-11-14
Ribavirin
Indication: Hepatitis C
Start date: 2011-11-14
Victrelis
Indication: Hepatitis C
Start date: 2011-12-12
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23
Patient: female
Reactions: White Blood Cell Count Decreased, Gait Disturbance, Coordination Abnormal, Asthenia, Decreased Appetite, Tremor
Drug(s) suspected as cause:
PEG-Intron
Dosage: 95 mcg qw sq
Indication: Hepatitis C
Start date: 2011-10-27
Ribasphere
Dosage: 1000 mcg daily po
Administration route: Oral
Start date: 2011-10-27
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2011-12-19
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Indication: Hepatitis C
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-09-20
Peginterferon Alfa-2B
Dosage: 4 df;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
Rebetol
Dosage: 2 df;qam;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
Other drugs received by patient: Deplin; Valtrex; Ibuprofen; Wellbutrin; Lysine; Effexor; Loratadine; Vitamin B Complex CAP
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2011-12-19
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Nausea, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded MK-5172
Indication: Hepatitis C
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-09-20
Peginterferon Alfa-2B
Dosage: 4 df;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
Rebetol
Dosage: 2 df;qam;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
Other drugs received by patient: Effexor; Valtrex; Deplin; Loratadine; Vitamin B Complex CAP; Lysine; Wellbutrin; Ibuprofen
Possible PEG-Intron side effects in 57 year old female
Reported by a physician from United States on 2011-12-14
Patient: 57 year old female, weighing 70.4 kg (154.9 pounds)
Reactions: Vomiting, Dehydration, Asthenia, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 4 df;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
PEG-Intron
Dosage: 0.4 ml;qw;sc
Indication: Hepatitis C
Start date: 2011-09-20
Rebetol
Dosage: 2 df;qam;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-20
Other drugs received by patient: Effexor; Loratadine; Ibuprofen; Valtrex; Wellbutrin; Vitamin B Complex CAP; Deplin; Lysine
|
